Tender Timeline
Introduction
The GEM/2025/B/6139922 tender is issued by the Department of Health and Family Welfare, under the Ministry of Health and Family Welfare. This tender aims to procure Acellular Dermal Matrix (V3), specifically designed to meet the health requirements for medical applications.
Scope of Work and Objectives
The primary objective of this tender is to solicit bids for the supply of 30 units of Acellular Dermal Matrix (V3). This product must comply with the relevant medical standards and regulations as stipulated by health authorities. The scope involves the delivery, installation, and quality assurance of the materials provided to ensure optimal performance and compliance with health safety standards.
Eligibility Criteria
To qualify for participation in this tender, bidders must demonstrate the following eligibility requirements:
- The bidder must be a registered entity in accordance with laws governing medical supplies.
- Prior experience in supplying similar products to government health departments or related organizations.
- Bidders must provide evidence of their capability to meet technical and financial requirements.
Technical Requirements
All submissions must include technical documentation showcasing the following:
- Specifications for the Acellular Dermal Matrix (V3).
- Compliance with applicable quality standards and certifications.
- Information regarding the manufacturing process and quality control measures in place.
Financial Requirements
Bid proposals must outline:
- A detailed cost breakdown for the delivery of the total quantity specified.
- Financial statements or reports verifying the bidder's financial stability and capability to fulfill the order.
Document Submission Details
Bids must be submitted electronically through the designated procurement platform, ensuring the following:
- All documents must be provided in widely accepted formats (PDF, DOCX).
- The submission must include a completed tender application form.
Special Provisions
The tender includes provisions aimed at supporting Micro, Small and Medium Enterprises (MSEs) and startups. Specific incentives may apply to eligible bidders as outlined in the policy guidelines.
Evaluation Process
Bids received will undergo a structured evaluation process focusing on:
- Compliance with technical specifications.
- Cost effectiveness.
- Past performance and reliability of the bidder.
Delivery Locations
The designated delivery locations will be specified in the finalized procurement order post-selection of the successful bidder.
Contact Information
For inquiries regarding this tender, bidders are encouraged to refer to the official contact points through the procurement platform, where further assistance will be provided.
This comprehensive description aims to clarify every aspect of the GEM/2025/B/6139922 tender, ensuring all potential bidders are informed and prepared to participate effectively.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
7 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, demonstrating experience in supplying medical products to government institutions, and providing adequate documentation related to both technical specifications and financial stability. Bidders should ensure their compliance with all necessary legal and regulatory frameworks governing medical supplies.
Bidders must submit complete documentation including technical specifications of the Acellular Dermal Matrix (V3), quality assurance certifications, detailed pricing structure, financial statements, and the completed tender application form in acceptable formats, such as PDF or DOCX, to facilitate the evaluation process.
The evaluation process involves a detailed review of each submitted bid focusing on compliance with the technical specifications outlined in the tender, the total pricing offered, and the past performance track records of the bidders. Bidders may be subject to additional assessments to verify their capabilities.
Payment terms will commence upon the successful delivery of the Acellular Dermal Matrix (V3), ensuring that all quality standards and compliance requirements are met. Detailed payment structures, including any advance payment conditions, will be outlined in the final contract agreement.
Yes, the tender offers specific benefits for Micro, Small, and Medium Enterprises (MSEs), including potential price preference during the bidding process, as well as any incentives aligned with national policy initiatives to promote local production and procurement. Bidders in this category are encouraged to confirm their eligibility to take advantage of these support measures.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders